FisclearFisclear

Financial Comparison

Dr. Reddy's Laboratories Limited vs Torrent Pharmaceuticals Limited

Click a ticker to view the full analysis.

DRREDDY.NS vs

In short

Torrent Pharmaceuticals Limited is the more profitable of the two, keeping 15.7% of revenue as net profit against 12.8% for Dr. Reddy's Laboratories Limited. Torrent Pharmaceuticals Limited trades at the higher trailing P/E (72.5× vs 30.5× for Dr. Reddy's Laboratories Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Dr. Reddy's Laboratories Limited and 1 for Torrent Pharmaceuticals Limited.

Based on filings for periods ending 31 Mar 2026 (DRREDDY.NS) and 31 Mar 2026 (TORNTPHARM.NS) · Updated

FisclearScore Comparison

DRREDDY.NS55Fair
TORNTPHARM.NS66Strong
Quality+9
83
74
Efficiency+13
47
60
Value+26
26
52
Cashflow+13
63
76
Regime
55
55
Peers+25
51
76

FisclearScore is a quantitative model. DRREDDY.NS shown solid · TORNTPHARM.NS shown dashed. Not financial advice.

MetricDRREDDY.NSTORNTPHARM.NS
Price₹1,188.00₹4,632.70
Market Cap₹989.6B₹1.76T
P/E (TTM)30.5x72.5x
P/B2.6x18.7x
Beta0.250.14
Div Yield0.65%0.81%
Revenue (TTM)₹335.9B₹137.5B
Net Income₹42.9B₹21.6B
Gross Margin52.8%74.4%
Risk Flags1 flag1 flag
Full DRREDDY.NS Report →Full TORNTPHARM.NS Report →

Related comparisons

Dr. Reddy's Laboratories vs Sun PharmaceuticalSun Pharmaceutical vs TORNTPHARM.NSCIPLA.NS vs Dr. Reddy's LaboratoriesDIVISLAB.NS vs Dr. Reddy's LaboratoriesAPOLLOHOSP.NS vs Dr. Reddy's LaboratoriesCIPLA.NS vs TORNTPHARM.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.